Complementary Genomic Screens Identify SERCA as a Therapeutic Target in NOTCH1 Mutated Cancer

被引：123

作者：

Roti, Giovanni ^{[1
,3
]}

Carlton, Anne ^{[1
,3
]}

Ross, Kenneth N. ^{[4
]}

Markstein, Michele ^{[5
]}

Pajcini, Kostandin ^{[6
,7
]}

Su, Angela H. ^{[1
,3
]}

Perrimon, Norbert ^{[8
,11
]}

Pear, Warren S. ^{[6
,7
]}

Kung, Andrew L. ^{[12
]}

Blacklow, Stephen C. ^{[2
,9
]}

Aster, Jon C. ^{[10
]}

Stegmaier, Kimberly ^{[1
,3
,4
]}

机构：

[1] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA

[2] Dana Farber Canc Inst, Canc Biol Program, Boston, MA 02215 USA

[3] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA

[4] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA

[5] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA

[6] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA

[7] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA

[8] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA

[9] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA

[10] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA

[11] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA

[12] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA

来源：

CANCER CELL | 2013年 / 23卷 / 03期

基金：

美国国家卫生研究院;

关键词：

SQUAMOUS-CELL TUMORS; C-MYC; MUTATIONS; GENE; LEUKEMIA; ACTIVATION; PRESENILIN; EXPRESSION; RECEPTOR; ATP2A2;

D O I：

10.1016/j.ccr.2013.01.015

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Notch1 is a rational therapeutic target in several human cancers, but as a transcriptional regulator, it poses a drug discovery challenge. To identify Notch1 modulators, we performed two cell-based, high-throughput screens for small-molecule inhibitors and cDNA enhancers of a NOTCH1 allele bearing a leukemia-associated mutation. Sarco/endoplasmic reticulum calcium ATPase (SERCA) channels emerged at the intersection of these complementary screens. SERCA inhibition preferentially impairs the maturation and activity of mutated Notch1 receptors and induces a G(0)/G(1) arrest in NOTCH1-mutated human leukemia cells. A small-molecule SERCA inhibitor has on-target activity in two mouse models of human leukemia and interferes with Notch signaling in Drosophila. These studies "credential" SERCA as a therapeutic target in cancers associated with NOTCH1 mutations.

引用

页码：390 / 405

页数：16

共 50 条

[31] Integrative phospho-proteomic and genomic analyses identify AXL as a potential biomarker and therapeutic target for NRAS-mutated melanoma
Fedorenko, Inna V.
Paraiso, Kim H. T.
Joseph, Beulah D.
Fang, Bin
Koomen, John
Eschrich, Steven
Nathanson, Katherine L.
Wubbenhorst, Bradly
Mathew, Rahel
Messina, Jane
Smalley, Keiran S. M.
CANCER RESEARCH, 2011, 71
[32] FBXW7 mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLL
Close, Viola
Close, William
Kugler, Sabrina Julia
Reichenzeller, Michaela
Yosifov, Deyan Yordanov
Bloehdorn, Johannes
Pan, Leiling
Tausch, Eugen
Westhoff, Mike-Andrew
Doehner, Hartmut
Stilgenbauer, Stephan
Oswald, Franz
Mertens, Daniel
BLOOD, 2019, 133 (08) : 830 - 839
[33] Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice
Klinakis, Apostolos
Szaboics, Matthias
Politi, Katerina
Kiaris, Hippokratis
Artavanis-Tsakonas, Spyros
Efstratiadis, Argiris
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (24) : 9262 - 9267
[34] The SERCA pump as a therapeutic target - Making a "smart bomb" for prostate cancer
Denmeade, SR
Isaacs, JT
CANCER BIOLOGY & THERAPY, 2005, 4 (01) : 14 - 22
[35] Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma
Wang, Simin
Xiong, Yangjie
Luo, Yuxiang
Shen, Yanying
Zhang, Fengrui
Lan, Haoqi
Pang, Yuzhi
Wang, Xiaofang
Li, Xiaoqi
Zheng, Xufen
Lu, Xiaojing
Liu, Xiaoxiao
Cheng, Yumei
Wu, Tanwen
Dong, Yue
Lu, Yuan
Cui, Jiujie
Jia, Xiaona
Yang, Sheng
Wang, Liwei
Wang, Yuexiang
EMBO MOLECULAR MEDICINE, 2024, 16 (05) : 1115 - 1142
[36] NOTCH1 MEDIATES PROTECTION IN COLITIS ASSOCIATED CANCER
Pujada, Adani
Tien Anh Bui
Walter, Lewins
Denning, Timothy L.
Garg, Pallavi
INFLAMMATORY BOWEL DISEASES, 2018, 24 : S29 - S30
[37] Overexpression of Notch1 is associated with the progression of cervical cancer
Sun, Yan
Zhang, Rui
Zhou, Shujuan
Ji, Yuqiang
ONCOLOGY LETTERS, 2015, 9 (06) : 2750 - 2756
[38] NOTCH1 MEDIATES PROTECTION IN COLITIS ASSOCIATED CANCER
Pujada, Adani
Bui, Tien Anh
Walter, Lewins
Denning, Timothy L.
Garg, Pallavi
GASTROENTEROLOGY, 2018, 154 (01) : S42 - S42
[39] Homing in on genomic instability as a therapeutic target in cancer
Bielski, Craig M.
Taylor, Barry S.
NATURE COMMUNICATIONS, 2021, 12 (01)
[40] Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry
Kluk, Michael J.
Ashworth, Todd
Wang, Hongfang
Knoechel, Birgit
Mason, Emily F.
Morgan, Elizabeth A.
Dorfman, David
Pinkus, Geraldine
Weigert, Oliver
Hornick, Jason L.
Chirieac, Lucian R.
Hirsch, Michelle
Oh, David J.
South, Andrew P.
Leigh, Irene M.
Pourreyron, Celine
Cassidy, Andrew J.
DeAngelo, Daniel J.
Weinstock, David M.
Krop, Ian E.
Dillon, Deborah
Brock, Jane E.
Lazar, Alexander J. F.
Peto, Myron
Cho, Raymond J.
Stoeck, Alexander
Haines, Brian B.
Sathayanrayanan, Sriram
Rodig, Scott
Aster, Jon C.
PLOS ONE, 2013, 8 (06):

← 1 2 3 4 5 →